BioSpace News Archive

Teen drivers diagnosed with attention-deficit hyperactivity disorder (ADHD) are significantly more likely to crash, be issued traffic and moving violations, and engage in risky driving behaviors than their peers without ADHD, according to a Children’s Hospital of Philadelphia (CHOP) study published today in the journal Pediatrics.

Smart Meter, an innovative diabetes management data, technology and solutions company, today announced a strategic agreement with AmeriHealth Caritas District of Columbia contracting to provide the iGlucose® Cellular Diabetes Care Solution to eligible members.

Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration products and solutions, today broke ground on a $15 million Material Research Center at its corporate headquarters in Bloomington, Minnesota.

The Biotechnology Innovation Organization (BIO) today announced that former U.S. Department of Agriculture (USDA) Secretary and former two-term Governor of Iowa Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation in Industrial Biotechnology

Galt Medical, a subsidiary of Theragenics Corporation® and a global supplier of access and procedure products for a range of interventional and endovascular procedures, today announced it has acquired Arrotek Medical Limited

HeartCare Imaging (HCI) has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare

Ocular Therapeutix™, Inc. announced topline results from the first pivotal Phase 3 clinical trial of OTX-TP, an intracanalicular insert that delivers a preservative-free formulation of the drug travoprost for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

Repro Med Systems, Inc. dba RMS Medical Products announced that Executive Chairman Dan Goldberger is scheduled to present at the 9th Annual LD Micro Invitational on June 5, 2019.

Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems announced it has entered into a definitive agreement to acquire Cancer Treatment Services International for $283 million.

Nevro Corp. announced that its Board of Directors has elected D. Keith Grossman, the Company’s President and CEO, to additionally serve as Chairman of the Board.